Ürtiker semptomlu atlarda plazma alkalen fosfataz, aspartat amino transferaz, laktat dehidrogenaz, gama glutamil transferaz, total protein, albumin ve lipid peroksidasyon düzeyleri

Bu çalışmanın amacı, urtiker semptomlu atlarda tedavi öncesi ve tedavi sonrası dönemde alkalen fosfataz (AP), aspartat amino transferaz (AST), Iaktat dehidrogenaz (LDH), gama glutamil transferaz (GGT), total protein (TP) ve albumin (ALB) gibi bazı biyokimyasal parametreler ile lipid peroksidasyon düzeylerini belirlemekti. Çalışmada ürtiker semptomlu 17 adet İngiliz atı kullanılmıştır. Tüm atların vena jugularislerinden vacutainer tüplere kan örnekleri alınmış, santrifüj edilerek plazmaları çıkarılmış ve kullanılıncaya kadar -20 °C'de saklanmıştır. Plazma biyokimyasal parametreleri ticari test kitleri kullanılarak otoanalizörle ölçülmüştür. Lipid peroksidasyon düzeyleri ise Placer'in metodu kullanılarak saptanmıştır. Tedavi öncesi ve sonrası dönem arasında AP, AST, LDH, GGT, TP ve ALB düzeyleri bakımından istatistiksel bir önem saptanmazken, lipid peroksidasyon düzeyleri bakımından istatistiksel önemlilik saptanmıştır.

The plasma alkalen phosphatase, aspartate amino transferase, lactate dehydrogenase, gama glutamy trnasferase, total protein, albumin and lipid peroxidation levels in horse with urticaria

The aim of this study, was to determine plasma biochemical parameters such as alkalen phosphatase (AP), aspartate amino transferase (AST), lactate dehydrogenase (LDH), gama glutamyl transferase (GGT), total protein (TP), albumin (ALB) and lipid peroxidation levels in the horses with urticaria at pre- and post-treatment period. In this study 17 standardbred horses with urticaria were used. Blood samples were collected in all horses from the jugular vein directly into vacutainer tubes, plasma was seperated by centrifugation and stored at -20CC until analysis. Plasma biochemical parameters were determined with an autoanalyser using commercial test kits. Lipid peroxidation levels were determined according to the method of Placer. There were no significant differences in plasma AP, AST, LDH, GGT, TP and ALB levels between pre- and post-treatment periods, but lipid peroxidation levels were significantly different (p

PDF

___

1. Logas DB, Barbat JL. Inflamatory, infectious, and immune disease. In: Colohan PT (Editor). Equine Medicine and Surgery, St. Louis, Mosby year book 1999: 868-1873.
2. Morıello KA, Deboer D, Semrad SD. Disease of the skin. In: Reed SM (Editor). Equine Internal Medicine, Philadelphia, W.B. Saunders 1998: 13, 557.
3. Vogelnest L, Mueller RS. Dermatology. In: Rose RJ (Editor), Manuel of Equine Practice, Second Edition, Philadelphia, W.B. Saunders 2000: 500.
4. Briganü S, Cristaudo A, D'Argento V, et al. Oxidative stres in physical urticarias. Clin Exp Dermatol 2001: 284-288.
5. Luger TA, Beissert S, Schwarz T. The epidermal cytokine network. In: Bos D. (Editor). Skin Immune System, Boca Raton, CRC Press 1997: 271-310.
6. Evans AG. Recurrent urticaria due to inhaled allergend. In: Robinson NE (Editor) Current Therapy in Equine Medicine, Philadelphia, W.B. Saunders, Second Edition 1986: 619-621.
7. Jose-Cunilleras E, Kohn CW, Hillier A, Saville WJ, Lorch G. Intradermal testing in healthy horses and horses with chronic obstructive pulmonary disease, recurrent urticaria or allergic dermatitis. J Am Vet Med Assoc 2001; 219: 1115-1121.
8. Scot DW, Miller WH. Equine Dermatology. St Louis, W.B. Saunders, 2003: 422-427.
9. Baulvelt A, Hwang ST, Udey MC. II. allergic and immunologic disease of the skin. J Allerg Clin Immunol 2003; 111: 560-570.
10. Zuberbıer T. Urticaria. Allergy 2003; 58: 1224-1234.
11. Rufenacht S, Marti E, von Tscharner C, et al. Immunoglobuline E-bearing cells and mast cells in skin biopsies of horses with urticaria. Vet Dermatol 2005; 16: 94-101.
12. Divers TJ. Liver disease and liver failure in horses. Procc 29 th Ann Conv Am Assoc Equine Pract 1983: 213.
13. Bernard W, Divers TJ, Zıemer E. Isoenzyme 5 of lactate dehidrogenase as an indicator of equine hepatocelluler disease. Vet Clin Pathol 1998; 17: 19.
14. Engelkıng LR, Paradis MR. Evaluation of hepatobiliary disease in the horse. In: Doxey DL (Editor) Clinical Pathology and Diagnostic Procedures, Philadelphia, W.B. Saunders, 1987: 563.
15. Duncan JR, Prasse KW. Veterinary Laboratory Medicine, Ames, Iowa State University Press, 1986: 121-132.
16. Reed S, Andrews FM. The biochemical evaluation of liver function in the horse. Proc 32 nd Ann Conv Am Assoc Equine Pract 1986: 81.
17. Placer AZ, Linda LC, Johnson B. Estamination of Product of Lipid Peroxidation (Malonly Dialdehyde) in Biochemical Systems. Anal Biochem 1966; 16: 359-364.
18. Hans DB, Hans RC, Wilson AM, Goodship A. ATP loss with exercise in muscle fibres of the gluteus medius of the througbred horse. Res Vet Sci 1997; 63: 231-237.
19. Mills PC, Smith NC, Casas I, et al. Effect of exercise intensity and environmental stres on indices of oxidative stres and iron homeostasis during exercise in the horse. Eurn J Appl Physiol 1996; 74: 60-66.
20. Ono K, Inuı K, Hasegawa T,et al. The changes of antioxidative enzyme activities in equine erythrocytes following exercise. Nippon Juigaku Zasshi 1990; 52: 759-765.
21. Snow DH, Hans RC, Gash SP. Metabolic response of equine muscle to intermittent maximal exercise. J Am Vet Physiol 1985; 58: 1689-1697.
22. Art T, Votron D, Lekeux P. Physiological measurements in horses after strenuous exercise in hot, humid conditions. Equine Vet J Suppl 1995; 20: 120-124.
23. Avellım L, Sılvestrellı M, Gaıtı A. Training-induced modifications in some biochemical defences against free radical in equine erythrocytes. Vet Res Commun 1995; 19: 179-184.
24. Kenan DM. Changes of plasma uric acid levels in horses after galloping. Res Vet Sci 1978; 25: 127-128.
25. Rose RJ, Hodgson DR, Jampson D, Stewart J, Chan W. Responses to submaximal treadmill exercise and training in the horse: changes in haemotology, arterial blood gas and acid base measurements, plasma biochemical values and heart rate. Vet Rec 1983; 113: 612-618.
26. Williamson LH, Andrews FM, Maykuth PL, White SL, Green EM. Biochemical changes in three day- event horses at the beginning, middle and end of phase C and after phase D. Equine Vet J Suppl 1996; 22: 92-98.
27. Deldar A, Fregin FG, Bloom JC, Dovanipour Z: Changes in selected biochemical constituents of blood collected from horses participating in a 160 km endurance ride. Aust Vet J 1982;43:2239-2243
28. Lucke JN, Hall GM. Long distance exercise in the horse: Golden Horseshoe Ride 1978. Vet Rec 1980; 106: 405-407.
29. Rose RJ, Purdue RA, Hensley W. Plasma biochemistry alterations in horses during an endurance ride. Equine Vet J 1977; 9: 122-126.
30. Freeman BA, Crapo JD. Free radicals and tissue injury. Lab Invest 1982; 47: 412-425.
31. Halhwel B, Chrica S. Lipid peroxidation. Its mechanism measurements and significance. Am J Clin Nutr 1999; 57 (supp): 715-725.
32. Kowalczuk K, Stryjecka-Zimmer M. The influence of oxidative stres on the level of malondialdehyde (MDA) in different areas of the rabbit brain. Ann Uni Mariae Curie Sklodowska (med) 2002; 57 (2): 160-164.
33. Allen RG, Tresini M. Oxidative stress and gene regulation. Free Rad Biol Med 2000; 28: 463-499.
34. Marlin DJ, Fenn K, Smith N,et al. Changes in circulatory antioxidant status in horses during prolonged exercise. Waltham International Symposium: Pet nutrition, Am Soc Nutr Sci 2002; 1622-1627.
35. Picardo M, Passi S. Free radicals. In: Bos D (Editor). Skin Immune System, Boca Raton, CRC Press, 1997; 207-226.
36. Raho G, Cassano N, D'Argento V, Vena GA, Zanotti F. Over-expression of Mn-Superoxide dismutase as a marker of oxidative stress in lesional skin of chronic idiopathic urticaria. Clin Exp Dermatol 2003; 28(3): 318-320.
37. Peng YS, Shyur SD, Lin HY, Wang CY. Steroid allergy: report of two cases. J Microbiol Immunol Infect 2001; 34 (2): 150-154.
38. Beytut E. İçme sularına E vitamini ve Selenyum ilave edilen radarda yüksek dozda kortizol verilmesinin oksidan ve antioksidan sistem üzerine etkileri. Doktora Tezi, Elazığ: Fırat Üniversitesi, Sağlık Bilimleri Enstitüsü, 2000.
39. Lee JW, Iwatsuru M, Nihigori H. Alteration of activities of hepatic antioxidant defence enzymes in developing chick embryo after glukokortikoid administration. A-factor produce some adverse effects. J Pharm Pharmacol 1998; 50(6): 655-666.